DKP Critical Insights® Syndicated Reports
DKP has developed a series of syndicated reports to provide perspectives into the oncology and rare-disease environment. The reports are designed to help you inform short- and long-term strategies that will support market positioning of your portfolio, as well as ongoing patient access to care.
DKP Critical Insights® Syndicated Reports include:
-
State Cancer Drug Parity Legislation – Oral vs. IV
-
Clinical Drug Compendia Overview Guide
-
Biopharmaceutical Manufacturer Patient Support Programs – Provider Perspectives
-
State Cancer Coverage Acts and Legislation
-
Commercial Payers’ Use of Compendia for Off-Label Oncology Uses
-
Clinical Pathways and Other Cancer Care Management Models: Trends and Evolution
-
State Biosimilars and Biologic Substitution Legislation
-
Medicaid Agency Use of Clinical Compendia
-
Medicaid PBM Influence on Oncology